The findings indicate that the glucose-stimulated insulin secretion (GSIS), insulin mRNA, and insulin content were reduced in the pancreatic islets of T2DM in comparison with the non-T2DM donors. This evidence concerns the gene INS and type 2 diabetes mellitus.